Tag: 58%

New PSMAddition data show 58% lower risk of PSA progression with Pluvicto in metastatic hormone-sensitive prostate cancer

More durable, deeper PSA response in patients treated with Pluvicto plus standard…

GlobeNews Wire

New World Lupus Federation Global Survey Finds 58% Know Very Little or Nothing About Lupus

Low familiarity and ongoing misconceptions underscore the need for increased education and…